Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis
Pharmacoepidemiology and Drug Safety · 2024
DOI: 10.1002/pds.70026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacoepidemiology and Drug Safety, 2024. Verfasst von Jeremy P Brown und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Pharmacoepidemiology, Bias, Confounding Factors, Epidemiologic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: GSK plc.
Abstract (Originalsprache)
Pharmacoepidemiological studies provide important information on the safety and effectiveness of medications, but the validity of study findings can be threatened by residual bias. Ideally, biases would be minimized through appropriate study design and statistical analysis methods. However, residual biases can remain, for example, due to unmeasured confounders, measurement error, or selection into the study. A group of sensitivity analysis methods, termed quantitative bias analyses, are available to assess, quantitatively and transparently, the robustness of study results to these residual biases. These approaches include methods to quantify how the estimated effect would be altered under specified assumptions about the potential bias, and methods to calculate bounds on effect estimates. This article introduces quantitative bias analyses for unmeasured confounding, misclassification, and selection bias, with a focus on their relevance and application to pharmacoepidemiological studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK.
- Epidemiology, Value Evidence and Outcomes, R&D Global Medical, GSK plc, Collegeville, Pennsylvania, USA.
- Real-World Analytics, Value Evidence and Outcomes, R&D Global Medical, GSK plc, Collegeville, Pennsylvania, USA.
- Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
- R&D, GSK Medicines Research Centre, GSK plc, Stevenage, UK.
ORCID-Profile: Christopher T Rentsch
Förderung
- GSK plc
Zitieren
APA
Brown, J. P., Hunnicutt, J. N., Ali, M. S., Bhaskaran, K., Cole, A., Langan, S. M., Nitsch, D., Rentsch, C. T., Galwey, N. W., Wing, K., & Douglas, I. J. (2024). Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis. Pharmacoepidemiology and Drug Safety. https://doi.org/10.1002/pds.70026
Vancouver
Brown JP, Hunnicutt JN, Ali MS, Bhaskaran K, Cole A, Langan SM, et al. Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis. Pharmacoepidemiology and Drug Safety. 2024. doi:10.1002/pds.70026
BibTeX
@article{Brown2024,
author = {Brown, Jeremy P and Hunnicutt, Jacob N and Ali, M Sanni and Bhaskaran, Krishnan and Cole, Ashley and Langan, Sinead M and Nitsch, Dorothea and Rentsch, Christopher T and Galwey, Nicholas W and Wing, Kevin and Douglas, Ian J},
title = {Core Concepts in Pharmacoepidemiology: Quantitative Bias Analysis},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2024},
doi = {10.1002/pds.70026}
}
EUVIMED